AntiviralsDevelopment of drug resistance: 13 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1734卷 / 1期

关键词：

D O I：

10.1007/s40278-019-56187-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：62 / 62

相关论文

共 50 条

[31] AfatinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2019, 1749 (1) : 22 - 22
[32] OsimertinibAcquired drug resistance: 22 case reports
Reactions Weekly, 2020, 1829 (1) : 304 - 304
[33] GanciclovirDevelopment of drug resistance : 2 case reports
Reactions Weekly, 2022, 1900 (1) : 152 - 152
[34] AntineoplasticsAcquired drug resistance: 5 case reports
Reactions Weekly, 2022, 1910 (1) : 53 - 53
[35] ErdafitinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2024, 2037 (1) : 172 - 172
[36] AntitubercularsAcquired drug resistance: 9 case reports
Reactions Weekly, 2023, 1982 (1) : 63 - 63
[37] Amoxicillin/fluconazoleFixed drug eruption: 13 case reports
Reactions Weekly, 2015, 1551 (1) : 32 - 32
[38] Multiple drugsAcquired drug resistance, drug resistance and treatment failure: 16 case reports
Reactions Weekly, 2025, 2047 (1) : 271 - 272
[39] VemurafenibSkin toxicity and drug resistance: 6 case reports
Reactions Weekly, 2019, 1749 (1) : 389 - 389
[40] Erlotinib/osimertinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2019, 1753 (1) : 161 - 161

← 1 2 3 4 5 →